These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 35931825)

  • 1. The role of the gut microbiota in multiple sclerosis.
    Correale J; Hohlfeld R; Baranzini SE
    Nat Rev Neurol; 2022 Sep; 18(9):544-558. PubMed ID: 35931825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Tract, Microbiota and Multiple Sclerosis (MS) and the Link Between Gut Microbiota and CNS.
    Yousefi B; Babaeizad A; Banihashemian SZ; Feyzabadi ZK; Dadashpour M; Pahlevan D; Ghaffari H; Eslami M
    Curr Microbiol; 2022 Dec; 80(1):38. PubMed ID: 36527519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
    Wing AC; Kremenchutzky M
    Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.
    Mestre L; Carrillo-Salinas FJ; Mecha M; Feliú A; Espejo C; Álvarez-Cermeño JC; Villar LM; Guaza C
    Front Immunol; 2019; 10():1374. PubMed ID: 31258540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotics and Commensal Gut Microbiota as the Effective Alternative Therapy for Multiple Sclerosis Patients Treatment.
    Dziedzic A; Saluk J
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probiotics: Potential novel therapeutics for microbiota-gut-brain axis dysfunction across gender and lifespan.
    Snigdha S; Ha K; Tsai P; Dinan TG; Bartos JD; Shahid M
    Pharmacol Ther; 2022 Mar; 231():107978. PubMed ID: 34492236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut-Microbiota, and Multiple Sclerosis: Background, Evidence, and Perspectives.
    Altieri C; Speranza B; Corbo MR; Sinigaglia M; Bevilacqua A
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.
    Glenn JD; Mowry EM
    J Interferon Cytokine Res; 2016 Jun; 36(6):347-57. PubMed ID: 27145057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
    Parodi B; Kerlero de Rosbo N
    Front Immunol; 2021; 12():718220. PubMed ID: 34621267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating Gut Microbiota: An Emerging Approach in the Prevention and Treatment of Multiple Sclerosis.
    Ullah H; Tovchiga O; Daglia M; Khan H
    Curr Neuropharmacol; 2021; 19(11):1966-1983. PubMed ID: 33596808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary Additive Probiotics Modulation of the Intestinal Microbiota.
    Hu S; Wang L; Jiang Z
    Protein Pept Lett; 2017; 24(5):382-387. PubMed ID: 28240160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The gut microbiota perspective for interventions in MS.
    Zoledziewska M
    Autoimmun Rev; 2019 Aug; 18(8):814-824. PubMed ID: 31176875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis.
    Ladakis DC; Bhargava P
    CNS Drugs; 2023 Feb; 37(2):117-132. PubMed ID: 36690786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Connecting the immune system, systemic chronic inflammation and the gut microbiome: The role of sex.
    Rizzetto L; Fava F; Tuohy KM; Selmi C
    J Autoimmun; 2018 Aug; 92():12-34. PubMed ID: 29861127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiomes in physiology: insights into 21st-century global medical challenges.
    Shehata E; Parker A; Suzuki T; Swann JR; Suez J; Kroon PA; Day-Walsh P
    Exp Physiol; 2022 Apr; 107(4):257-264. PubMed ID: 35081663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probiotics in Treatment of Viral Respiratory Infections and Neuroinflammatory Disorders.
    Shahbazi R; Yasavoli-Sharahi H; Alsadi N; Ismail N; Matar C
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33105830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Microbiota-Derived Metabolites Link the Gut to the Brain during Neuroinflammation.
    Rebeaud J; Peter B; Pot C
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and probiotics: novel immune system modulators in myasthenia gravis?
    Rinaldi E; Consonni A; Guidesi E; Elli M; Mantegazza R; Baggi F
    Ann N Y Acad Sci; 2018 Feb; 1413(1):49-58. PubMed ID: 29341125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in gut Microbiota mediated therapeutic targets in inflammatory bowel diseases: Emerging modalities for future pharmacological implications.
    Shamoon M; Martin NM; O'Brien CL
    Pharmacol Res; 2019 Oct; 148():104344. PubMed ID: 31400403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the gut microbiome in multiple sclerosis: From etiology to therapeutics.
    Shahi SK; Yadav M; Ghimire S; Mangalam AK
    Int Rev Neurobiol; 2022; 167():185-215. PubMed ID: 36427955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.